Atlas Trials

Stage IIIA2 Ovarian Cancer AJCC v8

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IIIA2 Ovarian Cancer AJCC v8

RecordFirmDate
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03735589)Roswell Park Cancer Institute2023-12-15
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer (NCT05415709)Ohio State University Comprehensive Cancer Center2022-06-13
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373)M.D. Anderson Cancer Center2022-04-29
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors (NCT07259304)University of Southern California2021-11-24
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors (NCT05039801)M.D. Anderson Cancer Center2021-09-30
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer (NCT04794322)Massachusetts General Hospital2020-04-13
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)City of Hope Medical Center2019-12-24
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study (NCT03707574)National Cancer Institute (NCI)2019-07-16
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery (NCT03943173)M.D. Anderson Cancer Center2019-06-07
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer (NCT03939481)SWOG Cancer Research Network2019-05-14
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT03907527)Precigen, Inc2019-04-30
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer (NCT03606486)University of Washington2018-11-16
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 (NCT02650986)Roswell Park Cancer Institute2017-07-14

Track Stage IIIA2 Ovarian Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.